🔎 Trials Near Me

홈 › 지방간질환 › 플로리다

플로리다의 지방간질환 임상 시험

지방간질환 관련 연구 21개가 플로리다 내 여러 지역에서 참여자를 모집하고 있습니다.

플로리다의 도시

공식 연구 텍스트(영어)

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

  • GSK Investigational Site, Brandon
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami Lakes
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT06613698

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Bradenton
  • Akero Clinical Study Site, Brandon
  • Akero Clinical Study Site, Coral Gables
  • 외 22개
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06528314

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  • Universal Axon Clinical Research, Doral
  • Southwest General Healthcare Center, Fort Myers
  • Genoma Research Group, Inc., Miami
  • 외 1개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07631637

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • Synergy Healthcare, Bradenton
  • Synergy Healthcare, Bradenton
  • Health Awareness, Inc., Jupiter
  • 외 6개
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07288138

Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  • Med Research of Florida, LLC, Miami
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07854782

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

  • GSK Investigational Site, Miami
  • GSK Investigational Site, Viera
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06920043

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • GSK Investigational Site, Cape Coral
  • GSK Investigational Site, Fort Myers
  • GSK Investigational Site, Hialeah
  • 외 7개
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • GSK Investigational Site, Cape Coral
  • GSK Investigational Site, Fort Myers
  • GSK Investigational Site, Hialeah
  • 외 7개
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07701993

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

  • GSK Investigational Site, Miami Lakes
  • GSK Investigational Site, Tampa
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07358546

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

  • Clinical Pharmacology of Miami, Miami
피험자 모집 중관찰 연구
18세 ~ 75세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT07122700

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Clermont
  • 89bio Clinical Study Site, Fort Myers
  • 89bio Clinical Study Site, Gainesville
  • 외 15개
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Brandon
  • 89bio Clinical Study Site, Clermont
  • 89bio Clinical Study Site, Fort Myers
  • 외 14개
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT06318169

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • K2 Medical Research WINTER GARDEN, Clermont
  • K2 Medical Research - Daytona Beach, Daytona Beach
  • Care Access - Delray Beach, Delray Beach
  • 외 20개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07165028

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

  • Health Awareness, Inc, Jupiter
  • Evolution Clinical Trials, Miami
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

  • University of Miami Health System, Miami
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05832229

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

  • GSK Investigational Site, Boynton Beach
  • GSK Investigational Site, Cape Coral
  • GSK Investigational Site, Clermont
  • 외 19개
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07221188

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

  • AdventHealth Translational Research Institute, Orlando
피험자 모집 중건강한 지원자 환영
25세 ~ 55세 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06993454

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

  • GSK Investigational Site, Boynton Beach
  • GSK Investigational Site, Cape Coral
  • GSK Investigational Site, Clermont
  • 외 20개
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT07221227

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  • Genoma Research Group, Inc, Miami
  • Med Research of Florida, LLC, Miami
피험자 모집 중1/2상건강한 지원자 환영
18세 ~ 75세 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT05648214

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

  • University of Florida, Gainesville
피험자 모집 중2상
21세 ~ 75세 · 모든 성별 · 2025. 4. 4. 업데이트됨 · NCT04501406

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

  • AdventHealth Translational Research Institute, Orlando
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2025. 3. 13. 업데이트됨 · NCT04807868

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.